IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,571,769 | +15.1% | 34,651 | +4.2% | 0.00% | 0.0% |
| Q2 2023 | $1,365,069 | +10.2% | 33,270 | -4.0% | 0.00% | 0.0% |
| Q1 2023 | $1,238,962 | -14.4% | 34,666 | -9.5% | 0.00% | 0.0% |
| Q4 2022 | $1,447,421 | -45.7% | 38,322 | -36.4% | 0.00% | -50.0% |
| Q3 2022 | $2,665,000 | -35.8% | 60,269 | -46.3% | 0.00% | -33.3% |
| Q2 2022 | $4,152,000 | +271.0% | 112,168 | +271.3% | 0.00% | +200.0% |
| Q1 2022 | $1,119,000 | +15.8% | 30,211 | -4.9% | 0.00% | 0.0% |
| Q4 2021 | $966,000 | -32.5% | 31,755 | -25.6% | 0.00% | 0.0% |
| Q3 2021 | $1,432,000 | -25.1% | 42,685 | -11.0% | 0.00% | 0.0% |
| Q2 2021 | $1,913,000 | -4.2% | 47,970 | +8.0% | 0.00% | 0.0% |
| Q1 2021 | $1,996,000 | -13.9% | 44,411 | +8.3% | 0.00% | -50.0% |
| Q4 2020 | $2,319,000 | +14.3% | 41,026 | -4.1% | 0.00% | 0.0% |
| Q3 2020 | $2,029,000 | -24.3% | 42,759 | -6.0% | 0.00% | 0.0% |
| Q2 2020 | $2,681,000 | +54.5% | 45,475 | +23.9% | 0.00% | 0.0% |
| Q1 2020 | $1,735,000 | -19.0% | 36,702 | +3.5% | 0.00% | 0.0% |
| Q4 2019 | $2,142,000 | -0.5% | 35,458 | -1.3% | 0.00% | 0.0% |
| Q3 2019 | $2,152,000 | -10.4% | 35,923 | -3.9% | 0.00% | 0.0% |
| Q2 2019 | $2,402,000 | -18.8% | 37,381 | +2.5% | 0.00% | -33.3% |
| Q1 2019 | $2,959,000 | +64.7% | 36,453 | +9.7% | 0.00% | +50.0% |
| Q4 2018 | $1,797,000 | -5.6% | 33,241 | -9.9% | 0.00% | 0.0% |
| Q3 2018 | $1,904,000 | +28.9% | 36,908 | +4.1% | 0.00% | +100.0% |
| Q2 2018 | $1,477,000 | -12.4% | 35,455 | -7.4% | 0.00% | -50.0% |
| Q1 2018 | $1,687,000 | -8.9% | 38,277 | +4.0% | 0.00% | 0.0% |
| Q4 2017 | $1,851,000 | +114.2% | 36,798 | +115.9% | 0.00% | +100.0% |
| Q3 2017 | $864,000 | -20.8% | 17,044 | -20.5% | 0.00% | 0.0% |
| Q2 2017 | $1,091,000 | +32.9% | 21,445 | +5.0% | 0.00% | 0.0% |
| Q1 2017 | $821,000 | -19.6% | 20,433 | -4.3% | 0.00% | 0.0% |
| Q4 2016 | $1,021,000 | +10.4% | 21,340 | -15.5% | 0.00% | 0.0% |
| Q3 2016 | $925,000 | +59.8% | 25,251 | +1.5% | 0.00% | 0.0% |
| Q2 2016 | $579,000 | -35.8% | 24,871 | +11.7% | 0.00% | 0.0% |
| Q1 2016 | $902,000 | -33.5% | 22,262 | +1.6% | 0.00% | -50.0% |
| Q4 2015 | $1,356,000 | – | 21,903 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |